Crescent Biopharma CBIO 深 沪
等待开盘 09-16 09:30:00 美东时间
12.22
-0.270
-2.16%
华盛通- 最 高12.93
- 今 开12.76
- 成交量 6.88万股
- 最 低 12.07
- 昨 收 12.49
- 总市值 788.56万
- 52周最高 74.00
- 市盈率 静 --
- 换手率 10.66%
- 52周最低 10.83
- 委 比 34.83%
- 总股本 64.53万
- 历史最高 3700.00
- 量 比 0.52
- 振 幅 6.89%
- 历史最低 10.83
- 每 手 1
- 风险率 0.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Tesla Stock Just Became A Buy Again, Finally: Expert
This trader thinks Tesla stock is ready to run into the end of the quarter.
09-12 23:39
Absci Boosts AI-Powered Drug Discovery With Oracle And AMD Collaboration
Absci teams up with Oracle and AMD to enhance AI-driven drug discovery using high-performance GPUs.
09-12 00:10
Ecovyst Streamlines Focus As Technip Energies Snaps Up Catalysts Business
Ecovyst Inc. (NYSE: ECVT) to sell Advanced Materials & Catalysts division to Technip Energies (OTC: THNPY) for $556M, reshaping strategic focus.
09-11 17:55
Health Catalyst appoints Ben Albert as President and COO
Health Catalyst (NASDAQ:HCAT) on Wednesday said it has appointed Ben Albert as President and Chief Operating Officer, effective immediately. Albert, brings over 25 years of experience in leading healt...
09-11 04:34
Ford revs up brand with first global ad push in 15 years
Ford (NYSE:F) launched its first new global ad campaign in 15 years to address shifting consumer preferences and to distinguish the 122-year old car company from the “sameness” within the rest of the ...
09-11 01:05
Methode Electronics surges on Q1 beat, maintains $900M–$1B sales outlook for FY26
Methode Electronics (NYSE:MEI) gained 10% in premarket trading on Wednesday after beating estimates for quarterly profit and revenue. Comparing the automotive segment’s quarter to the same quarter of ...
09-10 18:14
Jeff Bezos-Backed Slate Auto CEO Says Federal EV Tax Credit Removal Creates Battery Supply 'Opportunity'
The elimination of the federal electric vehicle tax credit may benefit newer market players, according to Slate Auto CEO Chris Barman.
09-10 14:52
Catalyst Metals Doubles Plutonic Belt Reserves, Targets Long-Term Growth
Catalyst Metals Limited ( ($AU:CYL) ) has shared an announcement. Catalyst Meta...
09-10 07:37
Johnson & Johnson gains approval of gemcitabine for local delivery into bladder
The U.S. FDA has granted approval to Johnson & Johnson's (NYSE:JNJ) Inlexzo (gemcitabine intravesical system), for certain types of bladder cancer. While gemcitabine was first approved in 1998 and is ...
09-10 05:07
